Cargando…
In vitro and in vivo pre-clinical analysis of a F(ab')(2 )fragment of panitumumab for molecular imaging and therapy of HER1-positive cancers
BACKGROUND: The objective of this study was to characterize the in vitro and in vivo properties of the F(ab')(2 )fragment of panitumumab and to investigate its potential for imaging and radioimmunotherapy. METHODS: The panitumumab F(ab')(2 )was generated by enzymatic pepsin digestion. Afte...
Autores principales: | Wong, Karen J, Baidoo, Kwamena E, Nayak, Tapan K, Garmestani, Kayhan, Brechbiel, Martin W, Milenic, Diane E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155408/ https://www.ncbi.nlm.nih.gov/pubmed/21845232 http://dx.doi.org/10.1186/2191-219X-1-1 |
Ejemplares similares
-
HER1-Targeted (86)Y-Panitumumab Possesses Superior Targeting Characteristics than (86)Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts
por: Nayak, Tapan K., et al.
Publicado: (2011) -
In Vitro and In Vivo Analysis of Indocyanine
Green-Labeled Panitumumab for Optical Imaging—A Cautionary
Tale
por: Zhou, Yang, et al.
Publicado: (2014) -
Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
por: Milenic, Diane E., et al.
Publicado: (2017) -
Pre-Clinical Assessment of (177)Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease
por: Ray, Geoffrey L., et al.
Publicado: (2011) -
Impact of α-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel
por: Yong, Kwon Joong, et al.
Publicado: (2014)